About LPATH
Lpat focuses on the discovery and development of monoclonal antibodies that target bioactive lipids.
Founded in 2006 by Roger Sabbadini.
- Founded
- 2006
- Employees
- 11 to 50
- Total funding
- $29.9M
Jobs at LPATH
No open positions right now. Explore more companies on TheJobsMap.